Sarah De Saeger Selected Research

Mycotoxins

1/2022	Multiple mycotoxin exposure during pregnancy and risks of adverse birth outcomes: a prospective cohort study in rural Ethiopia.
1/2021	Deoxynivalenol exposure assessment through a modelling approach of food intake and biomonitoring data - A contribution to the risk assessment of an enteropathogenic mycotoxin.
12/2020	At the scene of the crime: New insights into the role of weakly pathogenic members of the fusarium head blight disease complex.
1/2020	Dietary mycotoxins exposure and child growth, immune system, morbidity, and mortality: a systematic literature review.
1/2020	Mycotoxin exposure and human cancer risk: A systematic review of epidemiological studies.
1/2020	Mycotoxin exposure assessments in a multi-center European validation study by 24-hour dietary recall and biological fluid sampling.
11/2019	Mycotoxins in Flanders' Fields: Occurrence and Correlations with Fusarium Species in Whole-Plant Harvested Maize.
11/2017	Role of mycotoxins in herds with and without problems with tail necrosis in neonatal pigs.
1/2016	The Impact of Deoxynivalenol on Pigeon Health: Occurrence in Feed, Toxicokinetics and Interaction with Salmonellosis.
11/2015	Human biomonitoring of multiple mycotoxins in the Belgian population: Results of the BIOMYCO study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarah De Saeger Research Topics

Disease

6	Infections 12/2020 - 04/2010
6	Neoplasms (Cancer) 09/2020 - 01/2010
4	Body Weight (Weight, Body) 08/2018 - 04/2013
2	Mycotoxicosis (Fungus Poisoning) 11/2019 - 10/2019
2	Liver Failure 01/2019 - 01/2018
2	Vomiting 08/2018 - 01/2018
2	Malnutrition (Nutritional Deficiencies) 09/2017 - 07/2013
2	Enteritis 09/2015 - 01/2014
1	Pregnancy Complications 01/2022
1	Inflammation (Inflammations) 01/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022
1	Premature Birth (Birth, Premature) 01/2022
1	Food Hypersensitivity (Food Allergy) 01/2022
1	COVID-19 09/2021
1	Communicable Diseases (Infectious Diseases) 09/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 02/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Foodborne Diseases 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Child Nutrition Disorders 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2019
1	Nausea 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Necrosis 11/2017
1	Mycoses (Diseases, Fungus) 01/2017
1	Hemolysis 03/2016
1	Hypochromic Anemia (Chlorosis) 01/2016
1	Salmonella Infections (Salmonellosis) 01/2016
1	Carcinogenesis 10/2015
1	Dehydration (Water Stress) 01/2014
1	Weight Loss (Weight Reduction) 12/2012
1	Weight Gain 12/2012

Drug/Important Bio-Agent (IBA)

15	MycotoxinsIBA 01/2022 - 03/2012
6	deoxynivalenolIBA 01/2021 - 04/2013
3	AflatoxinsIBA 01/2020 - 09/2017
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2021
2	CarcinogensIBA 09/2020 - 01/2010
2	ZearalenoneIBA 01/2020 - 04/2013
2	Virulence Factors (Pathogenicity Factors)IBA 01/2020 - 01/2016
2	HT-2 toxinIBA 08/2018 - 04/2013
2	T-2 Toxin (T 2 Toxin)IBA 12/2012 - 03/2012
1	Biological ProductsIBA 01/2022
1	Trace Elements (Biometals)IBA 09/2021
1	jasmonic acid (jasmonate)IBA 12/2020
1	PatulinIBA 02/2020
1	CitrininIBA 02/2020
1	serum P-component (CIt)IBA 02/2020
1	fumonisin B1IBA 01/2020
1	ClayIBA 10/2019
1	Thioctic Acid (Lipoic Acid)IBA 01/2019
1	3-Mercaptopropionic Acid (3 Mercaptopropionic Acid)IBA 01/2019
1	amsonic acid (DAS)IBA 08/2018
1	diacetoxyscirpenolIBA 08/2018
1	Antineoplastic Agents (Antineoplastics)IBA 08/2018
1	cyclopiazonic acidIBA 01/2018
1	EmeticsIBA 01/2018
1	cereulideIBA 01/2018
1	Aflatoxin B1 (Aflatoxin B)IBA 01/2018
1	aspergillic acidIBA 01/2018
1	PolymersIBA 03/2016
1	tentoxinIBA 01/2016
1	FumonisinsIBA 09/2015
1	15-acetyldeoxynivalenolIBA 12/2014
1	3-acetyldeoxynivalenolIBA 12/2014
1	asparasoneIBA 01/2014
1	(1-6)-alpha-glucomannan (glucomannan)IBA 12/2012
1	prothioconazoleIBA 04/2010

Therapy/Procedure

1	Oral Administration 08/2018
1	Intravenous Administration 08/2018